Page 28 - Color Atlas Of Pathophysiology (S Silbernagl Et Al, Thieme 2000)
P. 28

Aging and Life Expectancy
       Aging is a normal, inevitable process that ends  in the accumulation of harmful somatic DNA
       with death. While the mean life expectancy of  mutations and in a decreasing telomer length,
       a newborn is estimated to have been a mere 10  which limits the ability of the cell to divide.
       years 50 000 years ago and ca. 25 years in an-  Many inherited diseases and (often polyge-
       cient Rome (→ A1), it is nowadays between 38  netically) inherited risk factors, have a second-
       (in Sierra Leone) and 80 years (Japan). It is  ary effect on life-span, e.g. in favoring the de-
       mainly due to decreased infant mortality and  velopment of certain tumors. Studies of mono-
       the effective treatment of infections (especial-  zygotic (uniovular) twins have, however,
       ly in children) that life expectancy in the in-  shown that at least two thirds of variability of
       dustrial nations has increased markedly in the  life-span is not genetically determined.
       past 100 years (e.g., in the USA from 42 to 72  As one gets older, a reduction of bodily func-
       years in men and to 79 in women). As a result,  tions (→ C) occurs as, for example, of maxi-
       diseases of the elderly are the most common  mum breathing capacity, cardiac output (CO),
       causes of death: ca. 50% are diseases of the  maximal O 2 uptake, and glomerular filtration
       cardiovascular system; 25% are tumors.
                                       rate (GFR). Muscle and bone mass decrease,
    Fundamentals  maximal life-span being reached, which, now  while the amount of fat increases, largely due
         These are largely diseases that prevent a
                                       to endocrine factors (→ D). For these reasons it
                                       is their frailty that is the limiting factor for
       as then, is about 100 years (→ A1). Thus, of
                                       most (otherwise healthy) very old persons.
       those aged 98 years, only 10% will still be alive
                                       diminished muscle power, slowed reflexes,
       (→ A2). The world record set by the French
    1  three years later and after 10 years only 0.005%  This weakness of old age is characterized by
       woman Jeanne Calment (122 years) is thus an  impaired mobility and balance, and reduced
       extremely rare exception.       stamina. The result is falls, fractures, reduced
         The causes of aging are unclear. Even indi-  daily physical activity, and loss of indepen-
       vidual cultured cells will “age”, i.e., after a cer-  dence. Muscle weakness is not only caused by
       tain number of cycles they stop dividing (fetal  physiological aging processes (→ D) and wear
       pulmonary fibroblasts after ca. 60 divisions;  and tear (e.g., damage to joints), but also by
       → B). Only a few cells are “immortal” (unlim-  lack of movement, leading to a vicious circle.
       ited proliferation, e.g., germinal, tumor, and  Purely age-related problems with memory
       hemopoietic stem cells). Life-span and age are  (especially problems of orientation in an unac-
       in part genetically determined. Thus, mutation  customed environment) seem to be caused by
       of the gene age-1 of the nematode can double  a disturbed long-term potentiation in the cor-
       its life-span, and the human gene that codes  tex and hippocampus (reduced density of glu-
       for DNA-helicase can cause premature aging  tamate receptors, type NMDA, in the dentate
       (progeria of the adult = Werner’s syndrome).  gyrus). It is now doubted whether a significant
       Recently a gene (MORF4) was discovered  loss of neurons, such as occurs in Alzheimer’s
       whose exclusion by mutation makes cultured  disease or atherosclerosis-induced reduction
       cells immortal: if the normal MORF4 gene is  in cerebral blood flow, is part of the normal
       passed to (immortal) cancer cells, it stops their  process of aging.
       proliferation. In “old” cells, MORF4 is up-regu-
       lated; in proliferating cells it is down-regu-
       lated. The age-1 mutation produces, among
       other effects, an increased resistance against
       free radicals. That oxidative damage is impor-
       tant for aging, is also suggested by the fact that
       membrane lipids, DNA, and proteins damaged
       by O 2 radicals accumulate with age, while at
       the same time the activity of enzymes that
   18  guard against oxidation is reduced. On the
       other hand, defects of the helicase gene result
       Silbernagl/Lang, Color Atlas of Pathophysiology © 2000 Thieme
       All rights reserved. Usage subject to terms and conditions of license.
   23   24   25   26   27   28   29   30   31   32   33